Vismodegib - Latest Advances

Low-dose oral minoxidil for the management of vismodegib-induced alopecia.

Journal: JAAD case reports

Published: October 17, 2025

A cell-based Sonic hedgehog signaling transduction system to identify additive and synergistic chemical interactions.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: October 15, 2025

Divergent late stage functionalisation of luminescent europium(III) complexes for targeting and imaging applications.

Journal: Chemical communications (Cambridge, England)

Published: October 09, 2025

Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Journal: JCO precision oncology

Published: October 09, 2025

Long-Term Management of Basal Cell Carcinoma Undergoing Reconstructive Procedures Before the Acquisition of Negative Margins.

Journal: Cureus

Published: September 03, 2025

A case of basal cell nevus syndrome with a SUFU mutation.

Journal: Dermatology online journal

Published: August 28, 2025

Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma.

Journal: Biochemical and biophysical research communications

Published: August 20, 2025

Vismodegib in locally advanced basal cell carcinoma: Nine-year real-world experience.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 04, 2025

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.

Journal: Dermatology online journal

Published: July 24, 2025

Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma.

Journal: Pharmaceutics

Published: July 22, 2025

Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology.

Journal: JAMA dermatology

Published: July 16, 2025

Remarkable Response to Vismodegib in a Locally Advanced Basal Cell Carcinoma on the Nose.

Journal: Cutis

Published: July 01, 2025

Filters

Low-dose oral minoxidil for the management of vismodegib-induced alopecia.

Low-dose oral minoxidil for the management of vismodegib-induced alopecia.

A cell-based Sonic hedgehog signaling transduction system to identify additive and synergistic chemical interactions.

A cell-based Sonic hedgehog signaling transduction system to identify additive and synergistic chemical interactions.

Divergent late stage functionalisation of luminescent europium(III) complexes for targeting and imaging applications.

Divergent late stage functionalisation of luminescent europium(III) complexes for targeting and imaging applications.

Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Long-Term Management of Basal Cell Carcinoma Undergoing Reconstructive Procedures Before the Acquisition of Negative Margins.

Long-Term Management of Basal Cell Carcinoma Undergoing Reconstructive Procedures Before the Acquisition of Negative Margins.

A case of basal cell nevus syndrome with a SUFU mutation.

A case of basal cell nevus syndrome with a SUFU mutation.

Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma.

Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma.

Vismodegib in locally advanced basal cell carcinoma: Nine-year real-world experience.

Vismodegib in locally advanced basal cell carcinoma: Nine-year real-world experience.

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.

Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma.

Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma.

Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology.

Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology.

Remarkable Response to Vismodegib in a Locally Advanced Basal Cell Carcinoma on the Nose.

Remarkable Response to Vismodegib in a Locally Advanced Basal Cell Carcinoma on the Nose.